
Sermorelin Pilot Study Shows Promise in Treating Depression in American Males
Reading Time: 2 minutes Introduction Depression remains a significant public health concern among American males, often leading to diminished quality of life and increased morbidity. Traditional pharmacological interventions, while effective for many, do not universally alleviate symptoms and can be accompanied by undesirable side effects. This has prompted exploration into alternative therapeutic modalities, one of which includes the use of Sermorelin, a synthetic analog of growth hormone-releasing hormone (GHRH). This article delves into a pilot study examining the potential of Sermorelin in improving mental health outcomes in American men diagnosed with depression. Background on Sermorelin Sermorelin functions by stimulating the pituitary gland to release...